Intravenous disopyramide, used for supraventricular tachycardia, can worsen ventricular dysrhythmia, leading to hypotension and potentially myocardial infarction. This case highlights the risks associated with disopyramide use in cardiac patients.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: